Nosopharm

OverviewSuggest Edit

Nosopharm is a young innovative biotechnology company dedicated to anti-infective drug discovery. Nosopharm addresses the unmet medical need of the bacterial multidrug resistance to antibiotics, a very concerning issue for hospital-acquired infections. Nosopharm has set up an innovative anti-infective drug discovery platform based on the medicinal mining of the microbial biodiversity. The Company has developed a unique expertise in the screening and the characterization of bioactive secondary metabolites produced by an original microbial bioresource: the bacterial genera Xenorhabdus and Photorhabdus.
TypePrivate
Founded2009
HQNîmes, FR
Websitenosopharm.com

Latest Updates

Employees (est.) (Oct 2019)11

Key People/Management at Nosopharm

Philippe Villain-Guillot

Philippe Villain-Guillot

Co-Founder and CEO
Maxime Gualtieri

Maxime Gualtieri

Co-Founder and CSO
Show more

Nosopharm Office Locations

Nosopharm has an office in Nîmes
Nîmes, FR (HQ)
110 Allée Charles Babbage
Show all (1)

Nosopharm Financials and Metrics

Summary Metrics

Founding Date

2009

Nosopharm total Funding

$3.8 m

Nosopharm latest funding size

$2.60 m

Time since last funding

3 years ago

Nosopharm investors

Nosopharm's latest funding round in March 2017 was reported to be $2.6 m. In total, Nosopharm has raised $3.8 m
Show all financial metrics

Nosopharm Online and Social Media Presence

Embed Graph

Nosopharm Blogs

Nosopharm and Evotec enter into collaboration to accelerate development of novel antibiotics

New partnership to advance Nosopharm’s lead candidate to clinical stage and develop second drug candidate NOSO-502 could be first novel antibiotic class against Enterobacteriace infections to enter clinics in forty years Lyon, France and Hamburg, Germany, July 3, 2019 – Nosopharm, a company dedicate…

Nosopharm appoints Dr Sarah Gould as chief development officer

Dr Gould brings her substantial expertise and network to the anti-infective company at a crucial time, ahead of entering the clinical stage with lead candidate NOSO-502 Lyon, France, November 12, 2018 – Nosopharm, a company dedicated to the research and development of new anti-infective drugs, annou…

Nosopharm Frequently Asked Questions

  • When was Nosopharm founded?

    Nosopharm was founded in 2009.

  • Who are Nosopharm key executives?

    Nosopharm's key executives are Philippe Villain-Guillot and Maxime Gualtieri.

  • How many employees does Nosopharm have?

    Nosopharm has 11 employees.

  • Who are Nosopharm competitors?

    Competitors of Nosopharm include Reata Pharmaceuticals, Otonomy and Vertex Pharmaceuticals.

  • Where is Nosopharm headquarters?

    Nosopharm headquarters is located at 110 Allée Charles Babbage, Nîmes.

  • Where are Nosopharm offices?

    Nosopharm has an office in Nîmes.

  • How many offices does Nosopharm have?

    Nosopharm has 1 office.